Author:
Geng Jiun-Hung,Chang Chun-Kai,Lee Cheng-Hsueh,Lin Chun-Hsuan,Li Ching-Chia,Wen Sheng-Chen,Yeh Hsin-Chih
Reference29 articles.
1. Combination alpha blocker and phosphodiesterase 5 inhibitor versus alpha-blocker monotherapy for lower urinary tract symptoms associated with benign prostate hyperplasia: A systematic review and meta-analysis;Chen;Urol Sci,2020
2. Update on AUA guideline on the management of benign prostatic hyperplasia;McVary;J Urol,2011
3. EAU Guidelines. Presented at the EAU Annual Congress Milan; 2021.
4. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines);Madersbacher;Eur Urol,2004
5. TURP for BPH.How large is too large?;Persu;J Med Life,2010